BEDFORD, Mass., May 20 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Glenn Muir, Chief Financial Officer, will present at the 8th Annual Needham Life Sciences Conference in New York on Wednesday, June 10, 2009 at 3:00 p.m. (Eastern) and the Jefferies 3rd Annual Healthcare Conference in New York on Wednesday, June 17, 2009 at 4:15 p.m. (Eastern).

Interested parties are invited to listen to live audio webcasts of Hologic's investor presentations on the investor section of the company's website at www.hologic.com/investor. Archives of the presentations will be available for replay following the conferences.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.

    Contact:    Deborah Gordon
                Vice President, Investor Relations
                Hologic, Inc.
                (781) 999-7716

SOURCE Hologic, Inc.